Ignite Creation Date:
2025-12-25 @ 1:35 AM
Ignite Modification Date:
2026-02-02 @ 2:58 AM
Study NCT ID:
NCT03297294
Status:
TERMINATED
Last Update Posted:
2021-10-08
First Post:
2017-09-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Painful Diabetic Neuropathy | View |